Jennifer Mccaney

UCLA Health is accepting applications for its TechQuity Accelerator. This program supports startups and other fledgling companies with technologies that can improve health equity among underserved and vulnerable patient populations.

Launched in 2022 in response to Covid-19’s effect on under-resourced and vulnerable communities, the TechQuity Accelerator strives to strengthen health security by targeting four overall areas: prevention, diagnosis, treatment and community impact.

The TechQuity Accelerator aims "to support early-stage companies driven by a commitment to develop inclusive technologies and boost health equity within diverse populations,” said Jennifer McCaney, executive director of UCLA Biodesign and associate director of the UCLA Clinical and Translational Science Institute.

Read Full Article at  LAINNO